Radiation Oncology Journal10.3857/roj.2021.010322022402151-161Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patientsChristos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis,,
Radiotherapy and Oncology10.1016/s0167-8140(15)33012-72013106S271PO-0706: Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II studyA. Magli, M.R. Malisan, E. Moretti, C. Foti, M. Crespi, M. Giangreco, A. Prisco, M. Poslinelli, G. Chiaulon, S. Fongione,
Radiotherapy and Oncology10.1016/s0167-8140(04)82035-8200473S77168 oral Hypofractionated intensity modulated irradiation for prostate cancer: results from a phase I/II study,
Radiotherapy and Oncology10.1016/s0167-8140(12)72519-7200992S42132 HYPOFRACTIONATED RADIOTHERAPY FOR LOW RISK PROSTATE CANCER: PRELIMINARY RESULTS OF A PHASE I/II TRIALC. Menkarios, D.H.A. Nguyen, É. Vigneault, N. Brochet, J.P. Bahary, M. Jolicoeur, T. Van Nguyen, M.C. Beauchemin, B. Fortin, M.A. Fortin, C. Lambert,
Radiotherapy and Oncology10.1016/s0167-8140(15)31426-22014111S91EP-1308: Phase II trial of pelvic nodal irradiation with hypofractionated IMRTSIB for high-risk prostate cancerA. Magli, T. Ceschia, E. Moretti, M. Signor, M. Polsinelli, A. Prisco, M. Crespi, C. Foti, M.R. Malisan, S. Fongione,
Radiotherapy and Oncology10.1016/s0167-8140(16)33452-12016120S2153: Acute and Late Toxicity in High-Risk Prostate Cancer Patients Treated with Androgen Suppression and Hypofractionated Radiotherapy (Hyport) to the Prostate and Pelvic NodesSergio Faria, Mariana Petrucelli, Fabio Cury, Marie Duclos, Luis Souhami,
Radiotherapy and Oncology10.1016/s0167-8140(18)31027-22018127S367PO-0717: Phase II study of hypofractionated stereotactic RT in recurrent HGG: preliminary resultsG.A. Carta,
Clinical Oncology10.1016/j.clon.2008.08.00620082010729-737Phase I/II Study of a Five-fraction Hypofractionated Accelerated Radiotherapy Treatment for Low-risk Localised Prostate Cancer: Early Results of pHART3C.I. Tang, D.A. Loblaw, P. Cheung, L. Holden, G. Morton, P.S. Basran, R. Tirona, M. Cardoso, G. Pang, S. Gardner, A. Cesta,
European Urology10.1016/j.eururo.2014.07.03620146661031-1032Radiobiological Modeling and the Study of Hypofractionated Radiotherapy for Prostate CancerMark K. Buyyounouski,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2010.07.8872010783S376Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to ProstateK. Reddy, B.C. Nelson, R. McCammon, K.E. Rusthoven, F. Newman, B. Kavanagh, D. Raben,